A9581 HCPCS Level II code: Injection, gadoxetate disodium, 1 ml

A9581 is the HCPCS code for “Injection, gadoxetate disodium, 1 ml” in CMS’s October 2026 release, in effect from Oct 1, 2026.

Official description

A9581

Injection, gadoxetate disodium, 1 ml

Short description: Gadoxetate disodium inj

HCPCS · United States

Medicare details

The indicators CMS publishes with A9581 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Carrier judgment
Medicare pricing
Drugs
Type of service
Medical care; Lump sum purchase of DME, prosthetics, orthotics
BETOS category
Advanced imaging - MRI/MRA: other
Added
Jan 1, 2010

Where A9581 sits

  1. 1A codesAmbulance, supplies and miscellaneous
  2. 2Active code A9581Injection, gadoxetate disodium, 1 ml

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does HCPCS code A9581 mean?

A9581 is the HCPCS code for “Injection, gadoxetate disodium, 1 ml” in CMS’s HCPCS Level II October 2026 release.

Does Medicare cover A9581?

CMS lists A9581’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.